Immunic Inc. buy Piper Sandler
Start price
17.07.24
/
50%
€1.33
Target price
17.07.25
€25.68
Performance (%)
-41.20%
End price
18.07.25
€0.78
Summary
This prediction ended on 18.07.25 with a price of €0.78. Massive losses of -41.20% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Immunic Inc. | - | - | - |
| iShares Core DAX® | 2,33 % | 1,01 % | 10,41 % |
| iShares Nasdaq 100 | 1,37 % | -3,61 % | 27,40 % |
| iShares Nikkei 225® | 2,44 % | -7,46 % | 49,84 % |
| iShares S&P 500 | 1,26 % | 0,68 % | 23,67 % |
Comments by Piper_Sandler for this prediction
In the thread Immunic Inc. diskutieren
Immunic, Inc. (NASDAQ: IMUX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $28.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat
In the thread Trading Immunic Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten